Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ines Vaz-Luis

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Cancer Treatment Reviews|January 24, 2025
Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussionStavroula L Kastora, Eirini Pantiora, Yong Hwa Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Aromatase Inhibitor-Induced Arthralgia Among Patients With Early Breast Cancer: Prevalence, Treatment Nonadherence, and Management in a Prospective Longitudinal CohortPietro Lapidari, Maryam B Lustberg, Julie Havas, et al.
Breast Cancer Research : BCR|February 19, 2025
Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal studyMylène Duivon, François Christy, Emilie Thomas, et al.
Scientific Reports|March 12, 2026
Return to work among self-employed breast cancer survivors from the CANTO cohortChloé Lopez, Idlir Licaj, Agnès Dumas, et al.
Breast Cancer Research and Treatment|September 24, 2021
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatiguePietro Lapidari, Nardjes Djehal, Julie Havas, et al.
Cancer|January 16, 2023
Baseline quality of life and chemotherapy toxicities in patients with early breast cancerIdlir Licaj, Elodie Coquan, Tienhan Sandrine Dabakuyo-Yonli, et al.
NPJ Breast Cancer|December 16, 2025
Author Correction: Advancing equitable access to innovation in breast cancerSeamus O'Reilly, Ines Vaz Luis, Virginie Adam, et al.
Journal of the National Cancer Institute|August 12, 2025
Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patientsMatteo Lambertini, Deirdre Allegranza, Ruediger P Laubender, et al.
Breast Cancer Research and Treatment|May 29, 2019
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trialMatteo Lambertini, Christine Campbell, Richard D Gelber, et al.
NPJ Breast Cancer|July 10, 2025
Advancing equitable access to innovation in breast cancerSeamus O'Reilly, Ines Vaz Luis, Virginie Adam, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reviews|January 24, 2025
Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussionStavroula L Kastora, Eirini Pantiora, Yong Hwa Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Aromatase Inhibitor-Induced Arthralgia Among Patients With Early Breast Cancer: Prevalence, Treatment Nonadherence, and Management in a Prospective Longitudinal CohortPietro Lapidari, Maryam B Lustberg, Julie Havas, et al.
Breast Cancer Research : BCR|February 19, 2025
Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal studyMylène Duivon, François Christy, Emilie Thomas, et al.
Scientific Reports|March 12, 2026
Return to work among self-employed breast cancer survivors from the CANTO cohortChloé Lopez, Idlir Licaj, Agnès Dumas, et al.
Breast Cancer Research and Treatment|September 24, 2021
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatiguePietro Lapidari, Nardjes Djehal, Julie Havas, et al.
Cancer|January 16, 2023
Baseline quality of life and chemotherapy toxicities in patients with early breast cancerIdlir Licaj, Elodie Coquan, Tienhan Sandrine Dabakuyo-Yonli, et al.
NPJ Breast Cancer|December 16, 2025
Author Correction: Advancing equitable access to innovation in breast cancerSeamus O'Reilly, Ines Vaz Luis, Virginie Adam, et al.
Journal of the National Cancer Institute|August 12, 2025
Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patientsMatteo Lambertini, Deirdre Allegranza, Ruediger P Laubender, et al.
Breast Cancer Research and Treatment|May 29, 2019
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trialMatteo Lambertini, Christine Campbell, Richard D Gelber, et al.
NPJ Breast Cancer|July 10, 2025
Advancing equitable access to innovation in breast cancerSeamus O'Reilly, Ines Vaz Luis, Virginie Adam, et al.
Pageof 13